Calcium upregulated survivin expression and associated osteogenesis of normal human osteoblasts

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 7, 2012, Pages 1770-1776

  Ortiz, Jan ^a   Chou, Laisheng Lee ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

apoptosis; biomaterial induced; calcium; osteoblasts; survivin

Indexed keywords

ALKALINE PHOSPHATASE; ALVEOLAR BONES; ANTI-APOPTOTIC PROTEIN; CALCIUM IONS; CELL ATTACHMENTS; CELL CYCLE; CONTROL GROUPS; DIFFERENTIATION MARKERS; EXTERNAL FACTORS; NORMAL HUMAN OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PARTS PER MILLIONS; STUDY GROUPS; SURVIVIN; UP-REGULATION; VITAMIN-D;

BIOLOGICAL MATERIALS; CALCIUM; CELL DEATH; CELL PROLIFERATION; MINERALOGY; OSTEOBLASTS; PHOSPHATASES;

CELL CULTURE;

ALKALINE PHOSPHATASE; CALCIUM; CALCIUM ION; COLECALCIFEROL; OSTEOCALCIN; SURVIVIN;

ALVEOLAR BONE; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NORMAL HUMAN; OSTEOBLAST; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE ENGINEERING; UPREGULATION; VITAMIN SUPPLEMENTATION;

ALKALINE PHOSPHATASE; CALCIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHOLECALCIFEROL; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; UP-REGULATION;

EID: 84861579545     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34103     Document Type: Article

References (67)

1. Delhalle S, Duvoix A, Schnekenburger M, Morceau F, Dicato M, Diederich M,. An introduction to the molecular mechanisms of apoptosis. Ann N Y Acad Sci 2003; 1010: 1-8.
2. Kerr JF, Wyllie AH, Currie AR,. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
3. Reed JC,. Mechanisms of apoptosis. Am J Pathol 2000; 157: 1415-1430.
4. Reed JC,. Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17: 2941-2953.
5. Salvesen GS, Dixit VM,. Caspases: Intracellular signaling by proteolysis. Cell 1997; 91: 443-446.
6. Thornberry N, Lazebnik Y,. Caspases: Enemies within. Science 1998; 281: 1312-1316.
7. Ambrosini G, Adida C, Altieri DC,. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917-921.
8. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC,. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998; 58: 5315-5320.
9. Johnson ME, Howerth EW,. Survivin: A bifunctional inhibitor of apoptosis protein. Vet Pathol 2004; 41: 599-607.
10. Mita AC, Mita MM, Nawrocki ST, Giles FJ,. Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 2008; 14: 5000-5005.
11. Wolanin K, Piwocka K,. Role of survivin in mitosis. Postepy Biochem 2007; 53: 10-18.
12. Ikeguchi M, Ueda T, Sakatani T, Hirooka Y, Kaibara N,. Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. Diagn Mol Pathol 2002; 11: 33-40.
13. Muzio L, Pannone G, Leonardi R, Staibano S, Mignogna MD, De Rosa G, Kudo Y, Takata T, Altieri DC,. Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res 2003; 82: 923-928.
14. Deveraux QL, Reed JC,. IAP family proteins - Suppressors of apoptosis. Genes Dev 1999; 13: 239-252.
15. Martinez A, Bellosillo B, Bosch F, Ferrer A, Marce S, Villamor N, Ott G, Montserrat E, Campo E, Colomer D,. Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. Am J Pathol 2004; 164: 501-510.
16. Rosa J, Canovas P, Islam A, Altieri DC, Doxsey SJ,. Survivin modulates microtubule dynamics and nucleation throughout the cell cycle. Mol Biol Cell 2006; 17: 1483-1493.
17. Yang D, Welm A, Bishop JM,. Cell division and cell survival in the absence of survivin. Proc Natl Acad Sci USA 2004; 10142: 15100-15105.
18. Altieri DC, Marchisio PC,. Survivin apoptosis: An interloper between cell death and cell proliferation in cancer. Lab Invest 1999; 79: 1327-1333; Erratum in: Lab Invest;79:1543. Marchisio C [corrected to Marchisio PC].
19. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC,. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396: 580-584.
20. Ortiz J, Marquez MG, and, Chou LL,. Survivin activity in normal human osteoblasts and osteosarcoma cells. Chin J Oral Maxillofac Surg 2010; 8: 241-249.
21. Auf'mkolk, B. PV, Schwarts ER,. Characterization of human bone cells in culture. Caicif Tissue Int 1985; 37: 228-235.
22. Robey PG, Termine JD,. Human bone cells in vitro. Calcif Tissue Int 1985; 37: 453-460.
23. Sodek J, Berkman FA,. Bone cell culture. Methods Enzymol 1987; 145: 303-324.
24. Freshney RI,. Culture of Animal Cells, a Manual of Basic Technique, 3rd ed. Wiley-Liss; New York, NY, USA 1994. p 227-229.
25. Manolagas SC, Burton DW, Deftos LJ, 1,25 Dihydroxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem 1981; 256: 7115-7117.
26. Owen TA, Aranow MS, Barone LM,. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 1991; 128: 1496-1504.
27. Stein GS, Lian JB,. Molecular mechanisms mediating proliferation- differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 1993; 14: 424-442.
28. Nijweide PJ, Burger EH, Feyen JH,. Cells of bone: Proliferation, differentiation, and hormonal regulation. Physiol Rev 1986; 66: 855-886.
29. Gillies RJ, Didier N, Denton M,. Determination of cell number in monolayer cultures. Anal Biochem 1986; 159: 109-113.
30. Barer MR, Lyon H, Drasar BS,. Quantitation of dye binding by cell monolayers in a microtiter system. Histochem J 1986; 18: 122-128.
31. Kueng W, Silber E, Eppenberger U,. Quantification of cells cultured on 96-well plates. Anal Biochem 1989; 182: 16-19.
32. Kostenuik PJ, Halloran BP, Morey-Holton ER, Bickle DD,. Skeletal unloading inhibits the in vitro proliferation and differentiation of rat osteoprogenitor cells. Am J Physiol 1997; 273 (6 Pt 1): E1133-E1139.
33. McMurtry MS, Archer SL, Altieri DC, Bonnet S, Haromy A, Harry G, Bonnet S, Puttagunta L, Michelakis ED,. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest 2005; 115: 1479-1491.
34. Khan Z, Khan N, Tiwari RP, Patro IK, Prasad GB, Bisen PS,. Down regulation of survivin by oxaliplatin diminishes radioresistance of head and neck squamous carcinoma cells. Radiother Oncol 2010; 96: 267-273.
35. Nabilsi NH, Broaddus RR, McCambell AS, Lu KH, Lynch HT, Chen LM, Loose DS,. Sex hormone regulation of survivin gene expression. J Endocrinol 2010; 207: 237-243.
36. Lu J, Murakami M, Verma SC, Cai Q, Haldar S, Kaul R, Wasik MA, Middeldorp J, Robertson ES,. Epstein-Barr virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. Virology 2011: 410: 64-75.
37. Bland-Brude OP, Mesri M, Wall NR,. Therapeutic targeting of the survivin pathway in cancer: Initiation of mitochondrial apoptosis and suppression of tumor associated angiogenesis. Clin Cancer Res 2003: 9: 2683-2692.
38. Mesri M, Morales-Ruiz M, Ackermann EJ,. Suppression of vascular endothelial growth factor mediated endothelial cell protection by survivin targeting. Am J Pathol 2001; 158: 1757-1765.
39. Altznauer F, Martinelli S, Yousefi S,. Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils. J Exp Med 2004; 199: 1343-1354.
40. Okada H, Bakal C, Shahinian A,. Survivin loss in thymocytes triggers p53-independent cell death. J Exp Med 2004; 199: 399-410.
41. Xing Z, Conway EM, Kang C, Winoto A,. Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation and homeostasis. J Exp Med 2004; 199: 69-80.
42. Gurbuxani S, Xu Y, Keerthivasan G,. Differential requirements for survivin hematopoietic cell development. Proc Natl Acad Sci USA 2005; 102: 11480-11485.
43. Fukuda S, Foster RG, Porter SB, Pelus LM,. The anti-apoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood 2002; 100: 2463-2471.
44. Fukuda S, Mantel CR, Pelus LM,. Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip 1- dependent and independent pathways. Blood 2004; 103: 120-127.
45. Fukuda S, Pelus LM,. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: Implication of survivin expression in normal hematopoiesis. Blood 2001; 98: 2019-2100.
46. Liang X, Da M, Zhuang Z, Wu W, Wu Z, Wu Y, Shen H,. Effects of survivin on cell proliferation and apoptosis in MG-63 cells in vitro. Cell Biol Int 2009; 33: 119-124.
47. Wu YF, Liang XJ, Liu YY, Gong W, Liu JX, Wang XP, Zhuang ZQ, Guo Y, Shen HY,. Antisense oligonucleotide targeting survivin inhibits growth by inducing apoptosis in human osteosarcoma cells MG-63. Neoplasma 2010; 57: 501-506.
48. Zou J, Gan M, Mao N, Zhu X, Shi Q, Yang H,. Sensitization of osteosarcoma cell line SaOS-2 to chemotherapy by down-regulating survivin. Arch Med Res 2010; 41: 162-169.
49. Palmieri A, Pezzetti F, Brunelli G, Ilaria Z, Carinci F,. A comparison between genetic portraits of normal osteoblasts and osteosarcoma cell lines. Indian J Dent Res 2009; 20: 52-59.
50. Sun J, Wei L, Liu X, Li J, Li B, Wang G, Meng F,. Influences of ionic dissolution products of dicalcium silicate coating on osteoblastic proliferation, differentiation and gene expression. Acta Biomater 2009; 5: 1284-1293.
51. Tsai SW, Chen CC, Chen PL, Hsu FY,. Influence of topography of nanofibrils of three-dimensional collagen gel beads on the phenotype, proliferation, and maturation of osteoblasts. J Biomed Mater Res A 2009; 91: 985-993.
52. Hofmann A, Ritz U, Hessmann MH, Alini M, Rommens PM, Rompe JD,. Extracorporeal shock wave-mediated changes in proliferation, differentiation, and gene expression of human osteoblasts. J Trauma 2008; 65: 1402-1410.
53. Nakade O, Takahashi K, Takuma T, Aoki T, Kaku T,. Effect of extracellular calcium on the gene expression of bone morphogenic protein-2 and -4 of normal human bone cells. J Bone Miner Metab 2001; 19: 13-19.
54. Bluteau G, Pilet P, Bourges X, Bilban M, Spaethe R, Daculsi G, Guicheux J,. The modulation of gene expression in osteoblasts by thrombin coated on biphasic calcium phosphate ceramic. Biomaterials 2006; 27: 2934-2943.
55. Eapen A, Sundivakkam P, Song Y, Ravindran S, Ramachadran A, Tiruppathi C, George A,. Calcium-mediated stress kinase activation by DMP1 promotes osteoblast differentiation. J Biol Chem 2010; 285: 36339-36351.
56. Chen Y,. In vitro effect of calcium on osteogenesis of human osteoblasts. WU 190 C518i 2000 Thesis (M.Sc.D.), Boston University, Henry M. Goldman School of Dental Medicine, 2000
57. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N,. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 2000; 6: 127-134.
58. Moriai R, Asanuma K, Kobayashi D, Yajima T, Yagihashi A, Yamada M, Watanabe N,. Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells. Anticancer Res 2001; 21: 595-600.
59. Berardi JM, Logan AC, Rao AV,. Plant based dietary supplement increases urinary pH. J Int Soc Sports Nutr 2008; 5: 20.
60. Liu G, Hu X, Varani J, Chakrabarty S,. Calcium and calcium sensing receptor modulates the expression of thymidylate synthase, NAD(P)H:quinone oxireductase 1 and survivin in human colon carcinoma cells: Promotion of cytotoxic response to mitomycin C and fluoracil. Mol Carcing 2009; 48: 202-211.
61. Kanatani M, Sugimoto T, Fakase M, Fujita T,. Effect of elevated extracellular calcium on the proliferation of osteoblastic MC3T3-E1 cells: Its direct and indirect effects via monocytes. Biochem Biophys Res Commun 1991; 181: 1425-1430.
62. Sugimoto T, Kanatani M, Kano J, Kobayashi T, Yamaguchi T, Fukase M, Chihara K,. IGF-I mediates stimulatory effects of high calcium concentration on osteoblastic cell proliferation. Am J Physiol 1994; 266 (5 Pt 1): E709-E716.
63. Mailland M, Waelchli R, Ruat M, Boddeke HG, Seuwen K,. Stimulation of cell proliferation by calcium and calcimimetic compound. Endocrinology 1997; 138: 3601-3605.
64. Matsouka H, Akiyama H, Okada Y, Ito H, Shigeno C, Konishi J, Kokubo T, Nakamura T,. In vitro analysis of the stimulation of bone formation by highly bioactive apatite- and wollastonite- containing glass ceramic: Released calcium ions promote osteogenic differentiation in the osteoblastic ROS17/2.8 cells. J Biomed Mater Res 1999; 47: 176-188.
65. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, TAssonari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS,. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990; 143: 420-430.
66. Li P, Nakanishi K, Kokubo T, de Groot K,. Induction and morphology of hydroxyapatite, precipitated from metastable simulated body fluids on sol-gel prepared silica. Biomaterials 1993; 14: 963-968.
67. Chang YL, Stanford CM, Keller JC,. Calcium and phosphate supplementation promotes bone cell mineralization: Implications for hydroxyapatite (HA)- enhanced bone formation. J Biomed Mater Res 2000; 52: 270-278.